Ensuring Product Stability - Choosing the Right Excipients.

Excipients Hydrolysis Moisture sorption Solid dosage forms Stability

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
08 2022
Historique:
received: 28 01 2022
revised: 02 05 2022
accepted: 02 05 2022
pubmed: 9 5 2022
medline: 20 7 2022
entrez: 8 5 2022
Statut: ppublish

Résumé

The stability of pharmaceuticals is an important product quality attribute. Of the known factors affecting stability, moisture is often perceived as the most common cause of drug degradation by hydrolysis or other reactions facilitated by moisture as a medium. Excipients are a critical entity in formulations to enable drug delivery as well as efficient manufacture of pharmaceutical dosage forms. Yet to this end, there is limited application and understanding of the role of excipients in protecting moisture sensitive drugs. An improved understanding of moisture-excipient interactions is important when selecting excipients for formulations containing moisture sensitive drugs. This review outlines the role of excipients as a moisture protectant in oral solid dosage forms. It focuses on the moisture interactions of excipients in order to highlight the potential of certain excipients as moisture protectants. More specifically, the mechanisms by which excipients can reduce drug degradation (e.g. acting as a physical barrier, reducing moisture availability and mobility) are discussed. A summary of analytical tools to evaluate moisture-excipient interactions is also provided.

Identifiants

pubmed: 35526577
pii: S0022-3549(22)00192-7
doi: 10.1016/j.xphs.2022.05.001
pii:
doi:

Substances chimiques

Excipients 0
Pharmaceutical Preparations 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2158-2171

Informations de copyright

Copyright © 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There are no conflicts of interest. The authors alone are responsible for the content and preparation of this manuscript.

Auteurs

Natalia Veronica (N)

GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.

Paul Wan Sia Heng (PWS)

GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.

Celine Valeria Liew (CV)

School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500 Subang Jaya, Selangor, Malaysia. Electronic address: celine.liew@monash.edu.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Animals Rumen Methane Fermentation Cannabis
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility
Chloramphenicol Poloxamer Hypromellose Derivatives Gels Drug Stability

Classifications MeSH